This article is more than 5 years old. Information may no longer be current.
OSN editorial board reviews and selects most insightful articles of 2005
Presbyopia-correcting IOLs, floppy iris syndrome and an off-label use of a drug to treat AMD were voted the most influential articles of the year.
Click Here to Manage Email Alerts
|
Richard L. Lindstrom |
In our 2004 Year in Review supplement, I had written that 2004 had begun with “the industry awaiting the approval of new technology IOLs,” and “a search for the holy grail of ophthalmology, a feasible treatment for presbyopia.”
So it was no surprise that when we polled our Editorial Advisory Board to find “what was hot” in 2005, most responses were for the article on private-pay option for presbyopia-correcting IOLs and for the article on the approval of two additional new technology IOLs.
In late fall, Ocular Surgery News contacted its Editorial Advisory Board and asked them to vote on their choice for the most influential and important issues reported in OSN in 2005.
Presbyopia-correcting IOLs
Topping our list is “CMS allows private-pay option for presbyopia-correcting IOLs” (June 1, 2005, page 1). This ruling has opened new doors for surgeons, as well as for their patients.
Our Editorial Board also ranked high the article that discussed the actual approval of the use two of these lenses, “Alcon, AMO, receive FDA approvals for presbyopia IOLs” (April 15, 2005, page 1).
Floppy iris syndrome
Second on the list was “Flomax associated with floppy iris syndrome in some men undergoing cataract surgery,” (February 15, 2005, page 1). Because it is likely that as the population in this country ages, more patients will be treated for prostate-related conditions, and that this may result in an increase in patients with floppy iris syndrome.
Avastin for AMD
“Avastin promising as anti-VEGF approach to AMD” (October 15, 2005, page 106), was also high on the list. One study found that a treatment with Avastin, which is approved for colon cancer, may be sufficient in some neovascular AMD patients.
And more
The remaining articles selected as best articles of 2005, including some special features that came late in the year and were unable to be reviewed by our board, are listed in the table of contents.
Please continue to follow Ocular Surgery News in 2006 to get the whole story.